The single biggest constraint on clinical AI is not computation or talent, it is data that can be shared. Real patient data is rightly difficult to move across institutions, and that difficulty has held back multi-center model development for a decade. High-quality synthetic data is the most credible path out of that bottleneck, and it is closer than most leaders assume.
In the Khalpey AI Lab, we are generating synthetic ECG signals through diffusion models and validating them against ground-truth cohorts with the same statistical discipline we apply to a clinical endpoint. The point is not that synthetic data is convenient. The point is that, validated properly, it preserves the structure that makes the real data useful while removing the patient-identifiability that makes it unshareable.
The risk is obvious and must be stated. Synthetic data validated carelessly is worse than no data, because it carries the appearance of rigor. A generative model can produce signals that look real and quietly omits the rare presentation that matters most. So synthetic data has to be validated like a drug: against ground truth, on the edge cases, with explicit characterization of where it diverges from reality.
Done to that standard, synthetic data lets institutions collaborate on AI development without moving a single identifiable record. It is how a mid-sized program contributes to and benefits from models it could never train alone. It is the foundation of a multi-center future that has been technically possible and practically blocked for years.
Hospital leaders should be asking their chief medical informatics officers a direct question: Do we have a synthetic data strategy, and has the synthetic data been validated against our ground truth? An institution that cannot answer is not behind on a nice-to-have. It is behind on the thing that will determine whether it can participate in the next decade of collaborative clinical AI.
Dr. Khalpey is chief medical AI officer at Atari AI, chair of applied clinical AI at the Atari AI Foundation and director of Khalpey AI Lab. He is a Fortune 500 advisor and author of The AI Prescription, an exploration into how AI enhances human expertise in medicine.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.